Cubist Announces Submission of New Drug Application for Investigational

Cubist Announces Submission of New Drug Application for Investigational

Filed under: drug treatment programs in massachusetts

LEXINGTON, MA, USA I October 22, 2013 I Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of its investigational antibiotic …
Read more on PipelineReview.com (press release)

 

Curis and Debiopharm Group™ Announce Initiation of Phase I Dose Finding

Filed under: drug treatment programs in massachusetts

LAUSANNE, Switzerland and LEXINGTON, MA, USA I October 22, 2013 I Curis, Inc. (NASDAQ: CRIS), an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based …
Read more on PipelineReview.com (press release)

 

Massachusetts Drug Overdose Deaths Up 47% Since 1999

Filed under: drug treatment programs in massachusetts

Despite the discouraging numbers, the report pointed out that Massachusetts already employs nine of TFAH's ten recommended strategies to help curb prescription drug abuse. Massachusetts currently has an active prescription drug-monitoring program, and …
Read more on GoLocal Worcester